Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.SCMC Trial on KHE With KMP (V.2020)
Condition: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) Interventions: Drug: prednison and Sirolimus; Drug: prednison Sponsor: Shanghai Children's Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials
